Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure - Baliga, RS; Preedy, MEJ; Dukinfield, MS; Chu, SM; Aubdool, AA; Bubb, KJ; Moyes, AJ; Tones, MA; Hobbs, AJ (Proceedings of the National Academy of Sciences, 2018)